Posts Tagged ‘Targvax’

Experimental mesothelioma vaccine posts promising results

7 May 2018 by under Research/Treatment

syringe vaccine 100x100 Experimental mesothelioma vaccine posts promising resultsBiotech company reported positive results from a limited, Phase I/II clinical study involving its oncolytic virus platform ONCOS-102 and standard-of-care chemotherapy (pemetrexed/cisplatin) in patients with unresectable malignant pleural mesothelioma. After six months, tumor sizes were successfully reduced in three out of six patients treated with the experimental therapy. One patient had a partial response, and the disease was stable in the remaining two patients. (more…)